Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 2001, p. 2494-2499, Vol. 39, No. 7
Departments of Physiological
Sciences1 and Pathobiology,
2 College of Veterinary Medicine, University of
Florida, Gainesville, Florida 32610, and Department of
Companion Animal and Special Species Medicine, College of
Veterinary Medicine, North Carolina State University, Raleigh, North
Carolina 276063
Received 16 November 2000/Returned for modification 4 March
2001/Accepted 8 April 2001
The major antigenic protein 2 (MAP2) of Ehrlichia
canis was cloned and expressed. The recombinant protein
was characterized and tested in an enzyme-linked immunosorbent
assay (ELISA) format for potential application in the
serodiagnosis of canine monocytic ehrlichiosis. The recombinant
protein, which contained a C-terminal polyhistidine tag, had a
molecular mass of approximately 26 kDa. The antigen was clearly
identified by Western immunoblotting using antihistidine antibody and
immune serum from an experimentally infected dog. The recombinant MAP2
(rMAP2) was tested in an ELISA format using 141 serum samples from
E. canis immunofluorescent antibody (IFA)-positive and
IFA-negative dogs. Fifty-five of the serum samples were from dogs
experimentally or naturally infected with E. canis and
were previously demonstrated to contain antibodies reactive with
E. canis by indirect immunofluorescence assays. The
remaining 86 samples, 33 of which were from dogs infected with
microorganisms other than E. canis, were seronegative.
All of the samples from experimentally infected animals and 36 of the
37 samples from naturally infected animals were found to contain antibodies against rMAP2 of E. canis in the ELISA. Only
3 of 53 IFA-negative samples tested positive on the rMAP2 ELISA. There was 100% agreement among IFA-positive samples from experimentally infected animals, 97.3% agreement among IFA-positive samples from naturally infected animals, and 94.3% agreement among IFA-negative samples, resulting in a 97.2% overall agreement between the two assays. These data suggest that rMAP2 of E. canis could
be used as a recombinant test antigen for the serodiagnosis of canine monocytic ehrlichiosis.
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.7.2494-2499.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Recombinant Major Antigenic Protein 2 of
Ehrlichia canis: a Potential Diagnostic
Tool
*
Corresponding author. Mailing address: Department of
Physiological Sciences, College of Veterinary Medicine, University of Florida, Box 100103C, Gainesville, FL 32610. Phone: (352) 392-4700, ext. 5858. Fax: (352) 392-1769. E-mail:
ALLEMANR{at}MAIL.VETMED.UFL.EDU.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|